Results 61 to 70 of about 15,580 (252)
Background: Atopic dermatitis (AD) is a common chronic eczematous skin disease with severe pruritus. Several new therapeutic agents for AD such as dupilumab, an anti–IL-4Rα antibody, have been developed in recent years.
Makiko Kido-Nakahara, MD +43 more
doaj +1 more source
Abdullah Alakeel,1 Afaf Al Sheikh,2,3 Ali A Alraddadi,4– 6 Khalid Mohammed Alattas,7 Maha Aldayel,8 Mohammed Abdulaziz Alajlan,9 Mohammed Al-Haddab,1 Mohammad Almohideb,3,10 Mohamed Fatani,11 Issam R Hamadah,12 Ruaa Alharithy,13,14 Yousef Binamer,15,16 ...
Alakeel A +13 more
doaj
Artificial Intelligence in Dermatology: Current Applications and Future Directions
This scoping review of 56 studies maps AI applications in dermatology. Image‐based classification for skin cancer detection dominates (48%), followed by clinical decision support (21%), teledermatology triage (11%), and predictive analytics (11%). While deep learning algorithms demonstrate diagnostic performance comparable to clinicians in controlled ...
Sofía Pérez‐Lalinde +1 more
wiley +1 more source
Netherton syndrome: effect on ichthyosis linearis circumflexa with dupilumab
Objectives To evaluate the efficacy of Dupilumab in treating Netherton Syndrome (SPINK5-sEDD).Methods We present a girl with SPINK5-sEDD who failed topical therapy.
Ashleigh Ka Ying Chu +4 more
doaj +1 more source
Atopic dermatitis:scoring severity and quality of life assessment
To provide a comprehensive assessment of atopic dermatitis severity, it is important to measure a combination of parameters: objective visual skin changes (clinical signs), patient symptoms and quality of life, as all three measures provide different ...
Carolyn R. Charman +3 more
core +1 more source
ABSTRACT Biologics and Janus kinase (JAK) inhibitors have transformed the management of atopic dermatitis (AD), yet some patients experience early worsening of disease activity during treatment initiation. In clinical trials, these events are typically recorded as treatment‐emergent adverse events (TEAEs), most commonly coded as “atopic dermatitis”. We
Diego Ruiz Dasilva +17 more
wiley +1 more source
Case report on Ayurvedic management of Eczema with special reference to Charma Kushta [PDF]
Skin inflammation is referred to as eczema, also referred to as dermatitis. Erythema, vesiculation, and oozing are the symptoms of acute eczema, followed by subacute scaling and crusting and chronic lichenification.
Neethu KS, Ajay Paul
core +1 more source
ABSTRACT Background Personalized treatment strategies for atopic dermatitis (AD) are limited. Although serum total IgE (tIgE) and blood eosinophil levels are proposed biomarkers for AD severity, their clinical utility requires validation. Objectives We aimed to identify biomarkers reflecting AD severity and their association with dupilumab efficacy ...
Zhuying Zhang, Jingwen Xue, Yi Zhao
wiley +1 more source
Skin samples of Hailey‐Hailey and Darier diseases were analyzed for inflammatory and barrier markers using indirect immunofluorescence and transcriptomic techniques. A mixed Th2/Th17 inflammatory pattern and altered expression of barrier markers were observed.
Ella Glodjajic +10 more
wiley +1 more source
Nail Psoriasis in Pediatric Populations
ABSTRACT Pediatric nail psoriasis is an under‐recognized yet clinically important manifestation of psoriasis with both diagnostic and prognostic implications. Nail involvement in children is associated with greater overall disease severity, poorer treatment outcomes, and is a predictor for the development of psoriatic arthritis.
Aditya K. Gupta +3 more
wiley +1 more source

